GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » Other Net Income (Loss)

No.25 Central Pharmaceutical JSC (HSTC:UPH) Other Net Income (Loss) : ₫ Mil (TTM As of . 20)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC Other Net Income (Loss)?

No.25 Central Pharmaceutical JSC's Other Net Income (Loss) for the six months ended in . 20 was ₫0.00 Mil. No.25 Central Pharmaceutical JSC does not have enough years/quarters to calculate its Other Net Income (Loss) for the trailing twelve months (TTM) ended in . 20.

No.25 Central Pharmaceutical JSC Other Net Income (Loss) Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC Other Net Income (Loss) Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
Other Net Income (Loss)

No.25 Central Pharmaceutical JSC Semi-Annual Data
Other Net Income (Loss)

No.25 Central Pharmaceutical JSC Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

No.25 Central Pharmaceutical JSC Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

No.25 Central Pharmaceutical JSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » Other Net Income (Loss)
Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
Website
https://uphace.vn
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines